Literature DB >> 1997164

Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway.

L A Akslen1, T Haldorsen, S O Thoresen, E Glattre.   

Abstract

Survival and prognostic factors were studied in 2479 clinically presenting thyroid cancers (TC) reported from the entire Norwegian population from 1970 to 1985. Complete follow-up was obtained (median, 48 months), with information on causes of death. At the end of the observation period, 498 patients were reported to have died of TC, representing 69.7% of all deaths. Among 216 patients dying of other main causes, TC was considered to be a contributing cause of death in 80 cases (11.2%). Multivariate regression analysis of TC deaths showed no significant difference according to sex in any of the histological types. Age had a strong impact on survival, and for papillary carcinomas this effect was apparent after the age of 55 years. Marked differences were observed between various histological types, even between papillary and follicular carcinomas when interactions were included. Furthermore, tumor stage was a strong predictor of TC deaths, and a reduced survival was also found in patients with lymph node metastases. In conclusion, the importance of age, histological type, and tumor stage as major prognostic factors has been documented in this population-based study from Norway.

Entities:  

Mesh:

Year:  1991        PMID: 1997164

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Role of GST and NAT2 polymorphisms in thyroid cancer.

Authors:  A Hernández; N Xamena; J Surrallés; P Galofré; A Velázquez; A Creus; R Marcos
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

2.  Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma.

Authors:  Radan Dzodic; Ivan Markovic; Momcilo Inic; Neven Jokic; Igor Djurisic; Milan Zegarac; Gordana Pupic; Zorka Milovanovic; Viktor Jovic; Nikola Jovanovic
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  Differentiated thyroid carcinomas: the relevance of various pathological features for tumour classification and prediction of tumour progress.

Authors:  L A Akslen; A O Myking
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

4.  The impact of age and gender on papillary thyroid cancer survival.

Authors:  J Jonklaas; G Nogueras-Gonzalez; M Munsell; D Litofsky; K B Ain; S T Bigos; J D Brierley; D S Cooper; B R Haugen; P W Ladenson; J Magner; J Robbins; D S Ross; M C Skarulis; D L Steward; H R Maxon; S I Sherman
Journal:  J Clin Endocrinol Metab       Date:  2012-04-10       Impact factor: 5.958

Review 5.  New insights in risk stratification of differentiated thyroid cancer.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

6.  BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer.

Authors:  Fei Wang; Shihua Zhao; Xiaopei Shen; Guangwu Zhu; Rengyun Liu; David Viola; Rossella Elisei; Efisio Puxeddu; Laura Fugazzola; Carla Colombo; Barbara Jarzab; Agnieszka Czarniecka; Alfred K Lam; Caterina Mian; Federica Vianello; Linwah Yip; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Bela Bendlova; Vlasta Sýkorová; Yangang Wang; Mingzhao Xing
Journal:  J Clin Oncol       Date:  2018-08-02       Impact factor: 44.544

7.  [Prognostic factors and the effect of radiotherapy in the treatment of differentiated thyroid carcinomas].

Authors:  I A Adamietz; M S Schiemann; J G Petkauskas; F Schemmann; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

8.  Association of XRCC1 polymorphisms with thyroid cancer risk.

Authors:  Cong Wang; Zhilong Ai
Journal:  Tumour Biol       Date:  2014-01-30

9.  Prognostic factors in patients with papillary thyroid carcinoma.

Authors:  O Soyluk; F Selcukbiricik; Y Erbil; A Bozbora; Y Kapran; N Ozbey
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

10.  Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.

Authors:  Yulan Yan; Feng Han; Huo Fu; Weiyi Xia; Xi Qin
Journal:  Tumour Biol       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.